Eldepryl 5mg is a prescription medication containing Selegiline 5mg, an MAO-B inhibitor primarily used in the treatment of Parkinson’s disease. It works by blocking the action of monoamine oxidase-B, an enzyme responsible for breaking down dopamine in the brain. By slowing dopamine breakdown, Eldepryl helps maintain higher dopamine levels, which can improve control over movement and reduce symptoms associated with Parkinson’s disease, including tremors, muscle stiffness, slowed movements, and poor coordination.
Eldepryl is commonly used in the early stages of Parkinson’s disease as monotherapy or in combination with levodopa/carbidopa in more advanced cases to enhance the effect of levodopa and help reduce “wearing-off” symptoms between doses. By supporting more stable dopamine activity, it may help improve mobility, reduce rigidity, and support better day-to-day functioning in people living with Parkinson’s disease.
This medicine should be taken exactly as prescribed by a healthcare professional. Since Selegiline may interact with certain medications and foods, it is important to inform the doctor about all ongoing treatments before starting therapy. Some people may experience side effects such as dizziness, nausea, dry mouth, insomnia, or headache. Because it can affect alertness in some individuals, caution is advised when driving or operating machinery until its effects are known.
Key Highlights
- Active ingredient: Selegiline 5mg
- Medicine class: Monoamine oxidase-B (MAO-B) inhibitor
- Used for: Management of Parkinson’s disease
- Works by: Preventing dopamine breakdown in the brain to improve motor symptom control
- Dosage form: Tablet
- Prescription status: Prescription-only medicine
Reviews
There are no reviews yet.